Jisu Han
Family Medicine · New York, NYNPI 1306322276
Payments from drug & device makers
Across 61 payments — averaging $24.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exact Sciences$334
- GSK$234
- Viiv Healthcare Company$215
- Amgen$87
- Astellas Pharma US Inc$69
- Novartis$67
- plus $512 from 16 others
What the payments were for
- Food & beverage$1,519100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exact Sciences | 11 | $334 |
| GSK | 8 | $234 |
| Viiv Healthcare Company | 10 | $215 |
| Amgen | 4 | $87 |
| Astellas Pharma US Inc | 2 | $69 |
| Novartis | 3 | $67 |
| Dexcom, Inc. | 2 | $64 |
| AbbVie | 2 | $52 |
| ANI Pharmaceuticals, Inc. | 2 | $52 |
| Phadia US Inc. | 3 | $48 |
| Shield Therapeutics Inc | 2 | $46 |
| Pfizer | 2 | $42 |
| Gilead | 1 | $33 |
| Hologic Sales And Service, LLC | 1 | $26 |
| Organon | 1 | $25 |
| Harmony Biosciences LLC | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $20 |
| Sanofi Pasteur Inc. | 1 | $19 |
| Intra-sana Laboratories | 1 | $17 |
| Merck | 1 | $17 |
| SK Life Science, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
How this compares
$1,519 in reported general payments places this provider in the 70th percentile of 4,321 family medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 17 | $24,129 |
| JardianceEmpagliflozin | 16 | $19,934 |
| JanuviaSitagliptin Phosphate | 12 | $11,570 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 40 | $1,647 |
| Atorvastatin Calcium | 76 | $1,051 |
| Omeprazole | 48 | $330 |
| Metformin Hcl | 45 | $223 |
| Lisinopril | 46 | $218 |
| Amlodipine Besylate | 37 | $164 |
| Levothyroxine Sodium | 14 | $164 |
| Diclofenac Sodium | 20 | $163 |
| Losartan Potassium | 21 | $157 |
| Rosuvastatin Calcium | 13 | $138 |
| Metoprolol Succinate | 15 | $106 |
| Fluticasone Propionate | 17 | $106 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia | $17 | $11,57012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,321 family medicine providers in New York.
Other family medicine in New York
- Matthew PabisNew York$222K
- Eric BatesNew York$171K
- Alexander BlinskiNew York$159K
- Jason KindtNew York$122K
- Punyadech PhotangthamNew York$107K
- Mahyar EidgahNew York$76K
- Anthony LyonNew York$65K
- Daniel BowersNew York$44K
- Matthew DavisRochester$76.6M
- Frank EderBinghamton$46.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.